Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

29.00 +1.61 (+5.90%)

Streaming Delayed Price Updated: 10:56 AM EDT, Aug 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

Hims & Hers' Chief Accounting Officer Is Leaving. Here's What Her Latest Insider Filing Shows ↗

Today 5:57 EDT

This filing notes that shares were withheld automatically to cover tax obligations from quarterly RSU vesting.

Via The Motley Fool

Topics Regulatory Compliance

An Insider at Hims & Hers Just Filed. Here's What It Says About Buying the Dip ↗

Today 5:49 EDT

Soleil Boughton retains roughly 339,000 shares and additional derivative securities.

Via The Motley Fool

Topics Regulatory Compliance

What Long-Term Investors Should Know About This Hims Insider Filing ↗

Today 5:41 EDT

Via The Motley Fool

Topics Regulatory Compliance

A Hims & Hers Insider Disposed of Stock as the Company Pushes Into Testosterone and Peptides. Here's What to Know ↗

Today 5:31 EDT

Tax withholding drove the disposal of 10,201 shares at $28.15 each, reducing this insider's direct holdings by 5%, though they're still up on a net basis given conversions.

Via The Motley Fool

Topics Regulatory Compliance

Hims & Hers' Policy Chief Just Filed an Insider Transaction. Here's What It Means. ↗

Today 5:23 EDT

This non-discretionary sale was tied to RSU tax withholding; the insider retains 65,734 direct shares and 428,000 derivative securities, per the filing.

Via The Motley Fool

Topics Regulatory Compliance

An Insider at Hims & Hers Disposed of Over $3 Million in Stock. Here's What Long-Term Investors Should Know ↗

Today 5:17 EDT

The disposition comes as HIMS stock has declined 38% over the past 12 months.

Via The Motley Fool

Topics Regulatory Compliance

The CTO of Hims & Hers Just Gave Up Nearly $2.7 Million in Stock. Here's What It Actually Means ↗

Today 5:08 EDT

This non-discretionary tax withholding reduced the CTO of Hims' direct holdings, though he retains roughly 194,000 shares and roughly 2 million derivative securities subject to multi-year vesting.

Via The Motley Fool

Topics Regulatory Compliance

Hims & Hers' CEO Just Disposed of 78,859 Shares. Here's What Long-Term Investors Should Know. ↗

Today 4:58 EDT

Stock-based compensation vesting triggered mandatory tax withholding, but Dudum retains about 9.7 million shares worth $272 million.

Via The Motley Fool

Topics Regulatory Compliance

Hims (HIMS) Q2 2026 Earnings Call Transcript ↗

August 17, 2026

Subscriber growth accelerated as revenue surged 38% and international expansion took off.

Via The Motley Fool

Topics Earnings

5 Revealing Analyst Questions From Hims & Hers Health’s Q2 Earnings Call

August 17, 2026

Hims & Hers Health’s second quarter results were driven by strong subscriber growth and a ramp-up in its branded weight loss offerings, yet the market reacte...

Via StockStory

Topics Artificial Intelligence Earnings

3 Market-Beating Stocks to Research Further

August 17, 2026

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ...

Via StockStory

Hims & Hers’ Revenue Beat Came With a Profitability Problem ↗

August 12, 2026

Hims & Hers topped Q2 revenue estimates and raised guidance, but missed EPS forecasts, posted a wider net loss, and faces an FTC lawsuit, leaving Wall Street cautious with a Hold rating.

Via MarketBeat

Topics Earnings Lawsuit

AI Capex Roars On After Hours as Hormuz Stress Keeps Traders on Edge ↗

August 12, 2026

Via Chartmill

Topics Artificial Intelligence

HIMS Q2 Deep Dive: AI Strategy and International Expansion Shape Telehealth Outlook

August 11, 2026

Telehealth company Hims & Hers Health (NYSE:HIMS) announced better-than-expected revenue in Q2 CY2026, with sales up 38.2% year on year to $753.2 million. On...

Via StockStory

Topics Artificial Intelligence

Wall Street Titans Line Up $500 Billion Behind Nvidia's AI Buildout ↗

August 11, 2026

Via Chartmill

Topics Artificial Intelligence

Hims & Hers Health Q2 Earnings Call Highlights ↗

August 10, 2026

Hims & Hers Health (NYSE:HIMS) reported second-quarter 2026 revenue of more than $753 million, up nearly 40% from a year earlier, as the telehealth company added 300,000 net new subscribers and ended...

Via MarketBeat

Topics Earnings

Hims & Hers Health (NYSE:HIMS) Exceeds Q2 CY2026 Expectations But Stock Drops

August 10, 2026

Telehealth company Hims & Hers Health (NYSE:HIMS) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 38.2% year on year to $753...

Via StockStory

Hims & Hers Health Earnings: What To Look For From HIMS

August 08, 2026

Telehealth company Hims & Hers Health (NYSE:HIMS) will be announcing earnings results this Monday after market hours. Here’s what to expect. Hims & Hers Heal...

Via StockStory

Topics Artificial Intelligence

1 Healthcare Stock Worth Your Attention and 2 We Ignore

August 07, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...

Via StockStory

The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic ↗

August 05, 2026

Hims & Hers Health shares have rallied despite an FTC lawsuit over data sharing and billing practices, as weight-loss drug partnerships and Wall Street's cautious Hold rating shape the stock's outlook...

Via MarketBeat

Topics Lawsuit

Is Hims & Hers Health Stock in Trouble? ↗

August 03, 2026

In the past 12 months, the stock has nosedived more than 50%.

Via The Motley Fool

Bearish Pressure Is Building Around These 3 Stocks ↗

August 03, 2026

Hims & Hers Health and QXO face heavy short interest amid dilution and loss concerns, while KLA has slid nearly 40% since June as AI-driven chip spending fears grip semiconductor stocks.

Via MarketBeat

Topics Artificial Intelligence

1 Russell 2000 Stock with Exciting Potential and 2 We Ignore

August 03, 2026

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...

Via StockStory

Topics Economy

2 Growth Stocks with Explosive Upside and 1 That Underwhelm

July 31, 2026

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...

Via StockStory

Topics Artificial Intelligence

2 Unprofitable Stocks for Long-Term Investors and 1 We Ignore

July 30, 2026

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...

Via StockStory

Topics Energy

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

July 24, 2026

What Happened? A number of stocks fell in the morning session after concerns grew over a rising number of uninsured patients. The trend was highlighted in HC...

Via StockStory

Why Is Hims & Hers Health Stock Surging on Thursday? ↗

July 23, 2026

Hims & Hers Health Inc (NYSE: HIMS) stock surges Thursday after an FDA advisory committee votes on adding BPC-157 to the allowed pharmacy compounding list.

Via Benzinga

1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds

July 22, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...

Via StockStory

Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years ↗

July 21, 2026

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 20.67% on an annualized basis producing an average annual return of 31.83%. Currently, Hims & Hers Health has a...

Via Benzinga

3 Reasons HIMS Has Explosive Upside Potential

July 17, 2026

Hims & Hers Health trades at $33.39 per share and has stayed right on track with the overall market, gaining 9.6% over the last six months. At the same time,...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.